- Puławska 38, 05-500 Piaseczno
- +48 792 850 530
- contact@neo-vinci.com
NEO-CRF is a tool that will make clinical trial management simpler, faster and more effective.
The NEO-CRF system is a solution that we have designed as a result of the need to improve, increase the scope and effectiveness of clinical and observational research conducted by pharmaceutical companies.
Firma Neo-Vinci sp. z o.o. jest dobrym partnerem w zakresie dostarczania narzędzi IT takich jak eCRF, IWRS oraz innych rozwiązań stosowanych w badaniach klinicznych.
Konsorcjum firm jest dobrym partnerem w zakresie serwisu CRO i należycie wykonuje swoje obowiązki w badaniu. Do dnia dzisiejszego nie stwierdzono krytycznych znalezisk w realizacji badania.
Kontrakt obsługiwany jest zgodnie z warunkami podpisanej umowy w zakresie wymagań funkcjonalności systemu i wsparcia technicznego. Firma zapewnia stały i bezpośredni kontakt w sprawach projektowych.
Let’s connect – call or message us, and we’ll handle the details together.
Yes, NEO-CRF integrates several components into one unified system, so there's no need to log in to separate platforms.
No, it is possible to use any application language depending on the study requirements and the Sponsor's needs.
Yes, NEO-CRF complies with GCP guidelines, FDA 21 CFR Part 11, as well as EMA and ICH guidelines, ensuring a complete audit trail, access control, and data security.
The costs depend on the scale of the study, the number of sites, and the system's functionality, but NEO-CRF reduces expenses related to paper documentation, monitoring, and data management, which often leads to long-term savings. The system can be implemented within a month after the contract is signed.
Experience the power of our eCRF system through the demo version. With complimentary access, you can verify its user-friendliness, features, and how well it meets your team's specific requirements. Take advantage of this chance to evaluate how our solution can enhance your processes and deliver seamless data management in your studies.
PL
